US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cybin Inc

6.79

+0.16002.41%

Volume:61.63K

Turnover:416.87K

Market Cap:142.83M

PE:-1.72

High:6.85

Open:6.59

Low:6.59

Close:6.63

Loading ...

Overview Company News Filings

Cybin, Segal Trials Collaborate to Advance Major Depressive Disorder Treatment

MT Newswires Live

Cybin launches clinical site partnerships to support PARADIGM program

Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

Cybin files $650M mixed securities shelf

Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results

Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024

Cybin Inc. Advances in Mental Health Treatments

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live

Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year

MT Newswires Live

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024

Cybin Inc : Alliance Global Partners Raises Target Price to $25 From $6

THOMSON REUTERS

Cybin reports Q2 results

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CYBN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYBN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYBN\",,,,,undefined,":{"symbol":"CYBN","market":"US","secType":"STK","nameCN":"Cybin Inc","latestPrice":6.79,"timestamp":1746802487594,"preClose":6.63,"halted":0,"volume":61627,"delay":0,"floatShares":18315492,"shares":21035921,"eps":-3.954937,"marketStatus":"Trading","change":0.16,"latestTime":"05-09 10:55:04 EDT","open":6.59,"high":6.85,"low":6.59,"amount":416873.129912,"amplitude":0.039216,"askPrice":6.79,"askSize":1,"bidPrice":6.7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.954937,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746820800000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":6.63,"preHourTrading":{"tag":"盘前","latestPrice":6.78,"preClose":6.63,"latestTime":"09:16 EDT","volume":2534,"amount":16706.631592,"timestamp":1746796575141},"postHourTrading":{"tag":"盘后","latestPrice":6.63,"preClose":6.63,"latestTime":"19:45 EDT","volume":2375,"amount":15558.8168,"timestamp":1746747900007},"volumeRatio":1.597704,"impliedVol":0.8636,"impliedVolPercentile":0.1765},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYBN\",,,,,undefined,":{"symbol":"CYBN","floatShares":18315492,"roa":"-44.06%","roe":"-57.49%","lyrEps":-6.948206,"volumeRatio":1.597704,"shares":21035921,"dividePrice":0,"high":6.85,"amplitude":0.039216,"preClose":6.63,"low":6.59,"week52Low":4.81,"pbRate":"0.83","week52High":14.44,"institutionHeld":0,"latestPrice":6.79,"committee":0.980198,"eps":-3.954937,"divideRate":0,"volume":61627,"delay":0,"ttmEps":-3.954937,"open":6.59,"prevYearClose":8.82,"prevWeekClose":6.5,"prevMonthClose":6.72,"prevQuarterClose":6.34,"fiveDayClose":6.5,"twentyDayClose":5.74,"sixtyDayClose":9.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CYBN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503767815","title":"Cybin, Segal Trials Collaborate to Advance Major Depressive Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2503767815","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503767815?lang=en_us&edition=fundamental","pubTime":"2025-01-16 02:03","pubTimestamp":1736964214,"startTime":"0","endTime":"0","summary":"Cybin  announced a partnership with closely held Segal Trials to support the multinational pivotal phase 3 program for evaluating CYB003 as a treatment for major depressive disorder.The phase 3 program plans to enroll 550 patients at more 40 clinical sites in the US and Europe, Cybin said Wednesday in a statement.Segal Trials, the first program member, has six research sites in South Florida with an emphasis on psychiatry, neurology, addiction and psychedelics, Cybin said.Shares of Cybin rose 4.8% in recent Wednesday trading.Price: 9.25, Change: +0.42, Percent Change: +4.78","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4168","CYBN","BK4007"],"gpt_icon":0},{"id":"2503070622","title":"Cybin launches clinical site partnerships to support PARADIGM program","url":"https://stock-news.laohu8.com/highlight/detail?id=2503070622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503070622?lang=en_us&edition=fundamental","pubTime":"2025-01-16 01:10","pubTimestamp":1736961011,"startTime":"0","endTime":"0","summary":"Cybin (CYBN) announced the launch of its first strategic partnership agreement with Segal Trials in furtherance of Cybin’s multinational pivotal Ph...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cybin-launches-clinical-site-partnerships-to-support-paradigm-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cybin-launches-clinical-site-partnerships-to-support-paradigm-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4168","CYBN"],"gpt_icon":0},{"id":"2503362715","title":"Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2503362715","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503362715?lang=en_us&edition=fundamental","pubTime":"2025-01-16 01:07","pubTimestamp":1736960820,"startTime":"0","endTime":"0","summary":"- Strategic Partnership Agreements will facilitate collaboration among sites, cultivate long term partnerships, enhance efficiency in trial operations, and improve overall site performance -. - First program member is Segal Trials, a preferred provider for leading pharmaceutical companies globally -. - Phase 2 data confirmed that two 16 mg doses of CYB003 administered three weeks apart provides remission from depression symptoms for 12 months in 71% of patients -. Segal Trials, the first program member, is a privately held company with a network of six research sites throughout South Florida. Segal Trials has extensive experience conducting research trials with an emphasis on psychiatry, neurology, addiction and psychedelics research.\"We are thrilled to collaborate with Cybin on its innovative Site Partnership Program. This partnership will accelerate learning at new sites around the country, enabling more research and could ultimately expedite the approval process for CYB003,\" said Bo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-launches-strategic-clinical-partnerships-170700548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CYBN","BK4007","BK4168"],"gpt_icon":0},{"id":"2503309108","title":"Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309108","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309108?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:30","pubTimestamp":1736771400,"startTime":"0","endTime":"0","summary":"- Announced positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder  -. - Initiated PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of MDD –。- Received U.S. Food and Drug Administration  Breakthrough Therapy Designation  for CYB003 for the Adjunctive Treatment of MDD -. - Topline efficacy data from Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder  expected in Q1 2025 -. TORONTO, January 13, 2025----Cybin Inc.   , a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to provide a year-end summary of its key accomplishments in 2024 and upcoming milestones for 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-highlights-2024-accomplishments-upcoming-123000251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABVC","BK4007","BK4139","BK4168","CYBN"],"gpt_icon":0},{"id":"2501747143","title":"Cybin files $650M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2501747143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501747143?lang=en_us&edition=fundamental","pubTime":"2025-01-08 19:11","pubTimestamp":1736334684,"startTime":"0","endTime":"0","summary":"06:05 EST Cybin (CYBN) files $650M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cybin-files-650m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cybin-files-650m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CYBN","BK4168"],"gpt_icon":0},{"id":"2490011816","title":"Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2490011816","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490011816?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:30","pubTimestamp":1733833800,"startTime":"0","endTime":"0","summary":"- Poster presentations highlight clinical data across Cybin’s CYB003 deuterated psilocin and DMT programs -. \"The ACNP annual meeting is an excellent opportunity to share the rapid clinical progress Cybin is making across our deuterated psilocin and DMT programs,\" said Doug Drysdale, Chief Executive Officer of Cybin. \"MDD affects roughly 21 million people in the U.S., alone, yet roughly two thirds do not experience relief from traditional antidepressant treatments. Developing new and improved treatments for MDD sufferers is a top priority for us. We look forward to engaging with the internationally distinguished researchers and scientists who share our passion to bring innovative therapeutics to the mental health space. With the recent initiation of our Phase 3 PARADIGM program evaluating CYB003 in MDD, this is a pivotal time for Cybin,\" concluded Drysdale. \"In addition to our CYB003 program, Cybin is advancing our deuterated DMT program, CYB004, which is currently in a Phase 2 General","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/lZ8GyFRM.GVp_M5etWmodg--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/285d90530d9c6a9223323463df832395","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/lZ8GyFRM.GVp_M5etWmodg--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/285d90530d9c6a9223323463df832395"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-announces-poster-presentations-2024-123000178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABVC","CYBN","AFG","BK4139","BK4007","BK4168","BK4117","BK4107"],"gpt_icon":0},{"id":"2488198851","title":"Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2488198851","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488198851?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:30","pubTimestamp":1733315400,"startTime":"0","endTime":"0","summary":"TORONTO, December 04, 2024----Cybin Inc.   , a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, and Amir Inamdar, MBBS, DNB , FFPM, Cybin’s Chief Medical Officer, will participate in the Water Tower Research Fireside Chat Series taking place on Wednesday, December 11, 2024, at 11:00 a.m. ET.The fireside chat will be hosted by Robert Sassoon, Senior Research Analyst at Water Tower Research. Covered topics will include:. CYB003’s 12-month efficacy data from its Phase II study for the treatment of major depressive disorder.The initiation of the Cybin’s Phase III PARADIGM program, its design, enrollment process, and milestone targets.To listen to the event, please click here to register for the webcast. The archived webcast will also be available on the Company’s investor relations website on the Ev","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LN0CwQjFn.ytBhVRi8b2EQ--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cd9f2888960b031d1155abe82662a92a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LN0CwQjFn.ytBhVRi8b2EQ--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cd9f2888960b031d1155abe82662a92a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-participate-water-tower-research-123000831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CYBN","BK4168","BK4007"],"gpt_icon":0},{"id":"2486193570","title":"Cybin Inc. Advances in Mental Health Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2486193570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486193570?lang=en_us&edition=fundamental","pubTime":"2024-11-26 11:58","pubTimestamp":1732593510,"startTime":"0","endTime":"0","summary":"Cybin, Inc. ( ($CYBN) ) has released its Q2 earnings. Here is a breakdown of the information Cybin, Inc. presented to its investors. Cybin Inc. is ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cybin-inc-advances-in-mental-health-treatments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cybin-inc-advances-in-mental-health-treatments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CYBN","BK4007","BK4168"],"gpt_icon":0},{"id":"2484673479","title":"Sector Update: Health Care Stocks Mixed Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2484673479","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484673479?lang=en_us&edition=fundamental","pubTime":"2024-11-18 22:19","pubTimestamp":1731939545,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Monday with the iShares Biotechnology ETF  0.2% higher and the Health Care Select Sector SPDR Fund  down 0.2% recently.Twist Bioscience  shares advanced by over 13% after the company reported a narrowed fiscal Q4 loss as revenue increased during the period.Shares of Regenxbio  rose by over 22% after the company reported new, positive data from the phase I/II portion of a study evaluating RGX-202 gene therapy for Duchenne muscular dystrophy.Cybin  shares were almost 13% higher after the company said data from a phase 2 study show that CYB003, a potential adjunctive treatment for major depressive disorder, offers \"sustained relief\" through one year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4585","TWST","RGNX","BK4007","BK4588","BK4139","BK4563","IBB","CYBN","XLV","BK4168","BK4581"],"gpt_icon":0},{"id":"2484221386","title":"Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2484221386","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484221386?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:09","pubTimestamp":1731935385,"startTime":"0","endTime":"0","summary":"Cybin  said Monday that data from a phase 2 study show that CYB003, a potential adjunctive treatment for major depressive disorder, offers \"sustained relief\" through one year.By 12 months, response rates for two 16-milligram doses of the drug given three weeks apart were 100% while 71% of the eight study participants were in remission, the company said.Cybin said it recently initiated a phase 3 trial to evaluate CYB003's effectiveness and safety in a larger number of patients. The drug earlier received Breakthrough Therapy Designation from the US Food and Drug Administration for major depressive disorder, Cybin added.The company also said it expects to report phase 2 results for CYB004 as a potential treatment for generalized anxiety disorder in Q1.Cybin shares were up 11% in recent premarket activity.Price: 12.89, Change: +1.29, Percent Change: +11.12","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4168","CYBN"],"gpt_icon":0},{"id":"2484629213","title":"Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629213","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484629213?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:00","pubTimestamp":1731931200,"startTime":"0","endTime":"0","summary":"- 100% of participants were responsive to treatment and 71% of participants were in remission at 12 months after just two 16 mg doses of CYB003 -. - Robust, long-term efficacy with ~23-point reduction in Montgomery-Asberg Depression Rating Scale  score compared to baseline at 12 months after two 16 mg doses of CYB003 -. - Findings validate dosing regimen and confirm that CYB003’s effects are highly durable and offer sustained relief for MDD patients -. - CYB003 continues to be well-tolerated and demonstrates an excellent safety profile -. - Cybin’s Phase 3 PARADIGM TM multinational pivotal program evaluating the efficacy and safety of CYB003 has been initiated -. This news release constitutes a \"designated news release\" for the purposes of Cybin’s prospectus supplements each dated August 23, 2023 for the Company’s ATM Program, to its short form base shelf prospectus dated August 17, 2023, as amended December 22, 2023 and April 8, 2024.\"Our Phase 2 study results are remarkable and valid","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GxPpfcw9coQXdElHEC9cyw--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/114d281654a815b6e42a12302d4b5be9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GxPpfcw9coQXdElHEC9cyw--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/114d281654a815b6e42a12302d4b5be9"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-reports-positive-phase-2-120000310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CYBN"],"gpt_icon":0},{"id":"2483874051","title":"Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483874051","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483874051?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:30","pubTimestamp":1731587400,"startTime":"0","endTime":"0","summary":"- Presentation will also include discussion of its recently initiated Phase 3 PARADIGM program for CYB003 -. TORONTO, November 14, 2024----Cybin Inc.   , a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that it will host a conference call and webcast on Monday, November 18, 2024 at 8:00 a.m. ET.The event will be hosted by Cybin’s Chief Executive Officer, Doug Drysdale, and Cybin’s Chief Medical Officer, Amir Inamdar, and will include presentation of 12-month efficacy and safety data from the Company’s Phase 2 study of CYB003 in Major Depressive Disorder and an overview of the design of its recently initiated Phase 3 PARADIGM program in CYB003. A Q&A session for the investment community will follow the prepared remarks.Certain statements in this news release relating to the Company are forward-looking statements and are prospective in nature. F","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/w1.s8daATdFv7AVBJbsUaQ--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9ab27420a79d2d7aef421cad0953af8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/w1.s8daATdFv7AVBJbsUaQ--~B/aD0yNjg7dz00NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9ab27420a79d2d7aef421cad0953af8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-present-12-month-phase-123000352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CYBN","BK4007","BK4168"],"gpt_icon":0},{"id":"2483876045","title":"Cybin Inc : Alliance Global Partners Raises Target Price to $25 From $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2483876045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483876045?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:06","pubTimestamp":1731585993,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3ML0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4168","CYBN","BK4007"],"gpt_icon":0},{"id":"2483004562","title":"Cybin reports Q2 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483004562","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483004562?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:36","pubTimestamp":1731501388,"startTime":"0","endTime":"0","summary":"Cybin press release (NYSE:CYBN): Q2 Net loss was C$57.2 million.\nCash totaled C$154.3 million as of September 30, 2024.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4284135-cybinreports-q-2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["CYBN","BK4007","BK4168"],"gpt_icon":0},{"id":"2483842004","title":"Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483842004","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483842004?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:30","pubTimestamp":1731501000,"startTime":"0","endTime":"0","summary":"- PARADIGM  program comprises two 12-week randomized, placebo-controlled studies  and a long-term extension study  -. - APPROACH : A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans with Major Depressive Disorder has been initiated and will enroll 220 patients at 36 clinical sites across the U.S. and Europe; topline results expected in 2026 -. \"Just three years after filing an Investigational New Drug application for CYB003, the initiation of our Phase 3 program is a truly significant and gratifying milestone,\" said Doug Drysdale, Chief Executive Officer of Cybin. \"Following a highly collaborative and thorough design and review process with the U.S. Food and Drug Administration, we believe that PARADIGM incorporates appropriate protocols that proactively address some of the challenges encountered by peers developing molecules with similar mechanisms of action by  recruiting from the larger MDD populat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8E1KZfTz0sWx.9LKB9rfkg--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/91e3f38405339535944d9c4c033a34fd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8E1KZfTz0sWx.9LKB9rfkg--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/91e3f38405339535944d9c4c033a34fd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cybin-initiates-paradigm-multinational-pivotal-123000583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4007","CYBN","ABVC","BK4168"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYBN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-19","symbol":"CYBN","defaultRemindTime":1726752600000,"type":"split","dateTimestamp":1726718400000,"forFactor":38,"toFactor":1,"ratio":38},{"market":"US","date":"2022-02-10","symbol":"CYBN","fiscalQuarterEnding":"2021/12","expectedEps":-0.09,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1644469200000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2021-11-15","symbol":"CYBN","fiscalQuarterEnding":"2021/09","expectedEps":-0.07,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1636952400000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2021-08-13","symbol":"CYBN","fiscalQuarterEnding":"2021/06","expectedEps":-0.05,"name":null,"time":"","type":"earning","dateTimestamp":1628827200000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYBN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CYBN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1741838400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CYBN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CYBN","date":"2025-05-08","current":-1.7477,"percent":0.910245,"low":-220.247266,"twenty":-10.655885,"median":-3.348784,"eighty":-2.039796,"high":-1.17733,"avg":-22.282076,"sd":46.83921,"marketCap":130633074},"quantilePoints":[{"date":"2020-11-13","current":-58.52688,"twenty":-69.746916,"median":-59.864848,"eighty":-58.398905,"marketCap":86446924},{"date":"2020-11-20","current":-49.399291,"twenty":-59.597254,"median":-55.044324,"eighty":-50.806644,"marketCap":73502859},{"date":"2020-11-27","current":-57.048799,"twenty":-58.398906,"median":-53.102864,"eighty":-50.383552,"marketCap":85436079},{"date":"2020-12-04","current":-84.307216,"twenty":-61.184664,"median":-56.959306,"eighty":-50.673697,"marketCap":127996585},{"date":"2020-12-11","current":-113.861502,"twenty":-90.25414,"median":-58.52688,"eighty":-51.176144,"marketCap":173418963},{"date":"2020-12-18","current":-158.818304,"twenty":-107.819251,"median":-61.180126,"eighty":-52.021371,"marketCap":241552530},{"date":"2020-12-24","current":-129.04801,"twenty":-128.739493,"median":-76.066836,"eighty":-53.491156,"marketCap":195605038},{"date":"2020-12-31","current":-128.209846,"twenty":-130.391202,"median":-89.262986,"eighty":-55.044324,"marketCap":195605038},{"date":"2021-01-08","current":-134.784009,"twenty":-130.531388,"median":-95.934049,"eighty":-56.869813,"marketCap":206107321},{"date":"2021-01-15","current":-167.705813,"twenty":-130.531388,"median":-113.234395,"eighty":-57.048799,"marketCap":255993170},{"date":"2021-01-22","current":-159.206584,"twenty":-144.429331,"median":-119.860672,"eighty":-57.975315,"marketCap":243208649},{"date":"2021-01-29","current":-142.626616,"twenty":-149.95371,"median":-125.680839,"eighty":-58.462893,"marketCap":216915822},{"date":"2021-02-05","current":-157.173138,"twenty":-150.974161,"median":-127.255716,"eighty":-59.63055,"marketCap":239151375},{"date":"2021-02-12","current":-161.058661,"twenty":-156.953257,"median":-128.209846,"eighty":-60.907242,"marketCap":246487306},{"date":"2021-02-19","current":-154.484848,"twenty":-157.008227,"median":-129.218204,"eighty":-61.184664,"marketCap":238321572},{"date":"2021-02-26","current":-128.917565,"twenty":-156.824137,"median":-130.461295,"eighty":-66.223491,"marketCap":197330573},{"date":"2021-03-05","current":-117.005551,"twenty":-156.181607,"median":-129.218204,"eighty":-77.366082,"marketCap":179228424},{"date":"2021-03-12","current":-110.637702,"twenty":-155.005392,"median":-128.563705,"eighty":-83.609556,"marketCap":172248404},{"date":"2021-03-19","current":-127.074339,"twenty":-154.007145,"median":-128.917565,"eighty":-90.25414,"marketCap":197482246},{"date":"2021-03-26","current":-111.555272,"twenty":-153.250664,"median":-128.208203,"eighty":-94.544812,"marketCap":172460136},{"date":"2021-04-01","current":-114.539362,"twenty":-151.966408,"median":-127.623792,"eighty":-95.230929,"marketCap":177163594},{"date":"2021-04-09","current":-135.933779,"twenty":-150.215873,"median":-128.20656,"eighty":-96.773065,"marketCap":210422802},{"date":"2021-04-16","current":-141.366713,"twenty":-149.899358,"median":-128.768172,"eighty":-98.321303,"marketCap":219844718},{"date":"2021-04-23","current":-128.226247,"twenty":-149.71772,"median":-128.226247,"eighty":-101.564115,"marketCap":199494066},{"date":"2021-04-30","current":-179.320718,"twenty":-150.373089,"median":-128.982788,"eighty":-105.793274,"marketCap":282972495},{"date":"2021-05-07","current":-162.585694,"twenty":-155.265665,"median":-130.211338,"eighty":-107.579749,"marketCap":260278495},{"date":"2021-05-14","current":-153.728594,"twenty":-157.054084,"median":-131.820178,"eighty":-110.38808,"marketCap":246910717},{"date":"2021-05-21","current":-147.200095,"twenty":-156.848854,"median":-133.917086,"eighty":-111.00473,"marketCap":237458912},{"date":"2021-05-28","current":-138.872279,"twenty":-156.379306,"median":-135.358894,"eighty":-111.655623,"marketCap":223320521},{"date":"2021-06-04","current":-144.817947,"twenty":-155.525937,"median":-136.589005,"eighty":-111.824676,"marketCap":232756600},{"date":"2021-06-11","current":-150.550712,"twenty":-154.38985,"median":-137.513752,"eighty":-111.975791,"marketCap":240702842},{"date":"2021-06-18","current":-172.668006,"twenty":-156.577005,"median":-138.031903,"eighty":-112.34852,"marketCap":269073583},{"date":"2021-06-25","current":-220.247266,"twenty":-158.225792,"median":-138.784546,"eighty":-112.858131,"marketCap":348324670},{"date":"2021-07-02","current":-12.807851,"twenty":-157.1701,"median":-138.031903,"eighty":-111.605448,"marketCap":334139502},{"date":"2021-07-09","current":-15.986534,"twenty":-157.157949,"median":-137.633877,"eighty":-105.818471,"marketCap":412945989},{"date":"2021-07-16","current":-17.462198,"twenty":-156.898287,"median":-137.20854,"eighty":-95.934049,"marketCap":446909323},{"date":"2021-07-23","current":-18.477492,"twenty":-156.774704,"median":-135.358894,"eighty":-82.563065,"marketCap":473205669},{"date":"2021-07-30","current":-19.709624,"twenty":-155.786209,"median":-133.917086,"eighty":-59.906468,"marketCap":509237067},{"date":"2021-08-06","current":-17.986825,"twenty":-155.774846,"median":-131.820178,"eighty":-56.869813,"marketCap":461105210},{"date":"2021-08-13","current":-10.51396,"twenty":-154.484848,"median":-130.211338,"eighty":-51.093324,"marketCap":358011137},{"date":"2021-08-20","current":-9.687344,"twenty":-154.009856,"median":-128.982788,"eighty":-49.277645,"marketCap":320859038},{"date":"2021-08-27","current":-11.72588,"twenty":-153.728594,"median":-128.226247,"eighty":-19.709624,"marketCap":395163236},{"date":"2021-09-03","current":-13.105421,"twenty":-153.688676,"median":-127.974359,"eighty":-18.285943,"marketCap":445825189},{"date":"2021-09-10","current":-12.131853,"twenty":-153.13155,"median":-127.289882,"eighty":-17.822943,"marketCap":408673090},{"date":"2021-09-17","current":-10.922933,"twenty":-152.965378,"median":-127.021489,"eighty":-17.351069,"marketCap":364766064},{"date":"2021-09-24","current":-11.682255,"twenty":-151.032301,"median":-125.853098,"eighty":-16.548015,"marketCap":391785772},{"date":"2021-10-01","current":-11.010445,"twenty":-150.492572,"median":-124.48212,"eighty":-14.801178,"marketCap":369832259},{"date":"2021-10-08","current":-10.38745,"twenty":-150.268141,"median":-122.517103,"eighty":-13.961976,"marketCap":354633673},{"date":"2021-10-15","current":-9.666588,"twenty":-150.003543,"median":-120.03546,"eighty":-13.353168,"marketCap":332680160},{"date":"2021-10-22","current":-9.61371,"twenty":-149.848205,"median":-118.329357,"eighty":-12.772015,"marketCap":330991428},{"date":"2021-10-29","current":-9.196519,"twenty":-149.612811,"median":-116.987421,"eighty":-12.42693,"marketCap":315792842},{"date":"2021-11-05","current":-11.403105,"twenty":-149.404702,"median":-113.234395,"eighty":-11.911086,"marketCap":390097041},{"date":"2021-11-12","current":-9.568382,"twenty":-149.364146,"median":-111.898782,"eighty":-11.672997,"marketCap":324236501},{"date":"2021-11-19","current":-6.119262,"twenty":-148.606467,"median":-111.096487,"eighty":-11.377461,"marketCap":278600036},{"date":"2021-11-26","current":-5.129837,"twenty":-148.127607,"median":-108.020069,"eighty":-11.182367,"marketCap":230742361},{"date":"2021-12-03","current":-5.287986,"twenty":-147.856855,"median":-98.755875,"eighty":-10.959231,"marketCap":237579172},{"date":"2021-12-10","current":-4.533789,"twenty":-147.620165,"median":-95.348116,"eighty":-10.74468,"marketCap":205104321},{"date":"2021-12-17","current":-4.569268,"twenty":-147.455833,"median":-84.307216,"eighty":-10.566477,"marketCap":205104321},{"date":"2021-12-23","current":-4.797133,"twenty":-147.337105,"median":-69.570608,"eighty":-10.448933,"marketCap":215359537},{"date":"2021-12-31","current":-4.512394,"twenty":-147.13856,"median":-60.531951,"eighty":-9.95564,"marketCap":205104321},{"date":"2022-01-07","current":-4.026096,"twenty":-147.031031,"median":-58.206944,"eighty":-9.872632,"marketCap":182884686},{"date":"2022-01-14","current":-3.914524,"twenty":-146.981877,"median":-55.957069,"eighty":-9.690344,"marketCap":179466281},{"date":"2022-01-21","current":-3.797135,"twenty":-146.927558,"median":-52.201619,"eighty":-9.624286,"marketCap":174338673},{"date":"2022-01-28","current":-3.905397,"twenty":-146.837192,"median":-50.393945,"eighty":-9.42966,"marketCap":176047876},{"date":"2022-02-04","current":-3.945168,"twenty":-146.548268,"median":-49.338468,"eighty":-9.288759,"marketCap":177757078},{"date":"2022-02-11","current":-3.683273,"twenty":-145.835595,"median":-20.068616,"eighty":-9.154697,"marketCap":183865933},{"date":"2022-02-18","current":-3.631699,"twenty":-145.479511,"median":-19.48019,"eighty":-6.516586,"marketCap":180396765},{"date":"2022-02-25","current":-3.170581,"twenty":-144.894575,"median":-18.785263,"eighty":-5.802438,"marketCap":157552290},{"date":"2022-03-04","current":-3.130529,"twenty":-144.817947,"median":-17.99342,"eighty":-5.419677,"marketCap":155245293},{"date":"2022-03-11","current":-2.752528,"twenty":-144.552992,"median":-17.758277,"eighty":-5.129837,"marketCap":137049503},{"date":"2022-03-18","current":-2.835391,"twenty":-143.796637,"median":-17.462198,"eighty":-4.771806,"marketCap":142183873},{"date":"2022-03-25","current":-2.516915,"twenty":-143.195217,"median":-17.169258,"eighty":-4.648729,"marketCap":127491944},{"date":"2022-04-01","current":-2.980874,"twenty":-142.990344,"median":-16.552103,"eighty":-4.56749,"marketCap":150908832},{"date":"2022-04-08","current":-2.578254,"twenty":-142.626616,"median":-16.012562,"eighty":-4.512394,"marketCap":129660174},{"date":"2022-04-14","current":-2.782146,"twenty":-142.192692,"median":-14.714908,"eighty":-4.432711,"marketCap":139616688},{"date":"2022-04-22","current":-2.512027,"twenty":-141.510213,"median":-14.174046,"eighty":-4.170171,"marketCap":125219639},{"date":"2022-04-29","current":-2.022512,"twenty":-140.995342,"median":-13.635896,"eighty":-4.011006,"marketCap":99912054},{"date":"2022-05-06","current":-1.815419,"twenty":-139.94537,"median":-13.400339,"eighty":-3.950555,"marketCap":89331090},{"date":"2022-05-13","current":-1.456163,"twenty":-139.039041,"median":-13.084121,"eighty":-3.912699,"marketCap":71291413},{"date":"2022-05-20","current":-2.077034,"twenty":-138.826329,"median":-12.628671,"eighty":-3.887798,"marketCap":102427201},{"date":"2022-05-27","current":-2.259667,"twenty":-138.790605,"median":-12.473479,"eighty":-3.81856,"marketCap":112244948},{"date":"2022-06-03","current":-2.706135,"twenty":-138.409415,"median":-12.247704,"eighty":-3.788288,"marketCap":136164865},{"date":"2022-06-10","current":-2.349603,"twenty":-138.095453,"median":-11.936471,"eighty":-3.68505,"marketCap":116234492},{"date":"2022-06-17","current":-2.040431,"twenty":-138.02771,"median":-11.718754,"eighty":-3.421766,"marketCap":98958033},{"date":"2022-06-24","current":-1.978293,"twenty":-137.908163,"median":-11.659111,"eighty":-3.242555,"marketCap":103579727},{"date":"2022-07-01","current":-1.895823,"twenty":-137.657902,"median":-11.425306,"eighty":-3.125139,"marketCap":99277130},{"date":"2022-07-08","current":-2.12523,"twenty":-137.484474,"median":-11.274886,"eighty":-2.910808,"marketCap":111091637},{"date":"2022-07-15","current":-2.040272,"twenty":-137.335597,"median":-11.171954,"eighty":-2.816145,"marketCap":106013162},{"date":"2022-07-22","current":-1.890532,"twenty":-136.960726,"median":-11.010445,"eighty":-2.793715,"marketCap":99435832},{"date":"2022-07-29","current":-1.985759,"twenty":-135.962332,"median":-10.894604,"eighty":-2.782959,"marketCap":104785085},{"date":"2022-08-05","current":-2.427545,"twenty":-135.703825,"median":-10.753652,"eighty":-2.749354,"marketCap":126821888},{"date":"2022-08-12","current":-2.784971,"twenty":-134.620912,"median":-10.664106,"eighty":-2.749354,"marketCap":143586504},{"date":"2022-08-19","current":-3.112575,"twenty":-133.958236,"median":-10.550204,"eighty":-2.737418,"marketCap":157945155},{"date":"2022-08-26","current":-3.571727,"twenty":-133.896136,"median":-10.454721,"eighty":-2.749354,"marketCap":181277962},{"date":"2022-09-02","current":-3.777356,"twenty":-133.671663,"median":-10.272763,"eighty":-2.754613,"marketCap":190252118},{"date":"2022-09-09","current":-2.974863,"twenty":-133.108969,"median":-9.910731,"eighty":-2.762951,"marketCap":150424812},{"date":"2022-09-16","current":-2.242934,"twenty":-130.531388,"median":-9.876312,"eighty":-2.734633,"marketCap":111459024},{"date":"2022-09-23","current":-2.011467,"twenty":-130.391202,"median":-9.791996,"eighty":-2.70966,"marketCap":97818306},{"date":"2022-09-30","current":-1.807939,"twenty":-130.211338,"median":-9.691094,"eighty":-2.662686,"marketCap":86869835},{"date":"2022-10-07","current":-2.237382,"twenty":-129.218204,"median":-9.666588,"eighty":-2.614465,"marketCap":107851413},{"date":"2022-10-14","current":-2.158629,"twenty":-129.04801,"median":-9.590848,"eighty":-2.571586,"marketCap":102664350},{"date":"2022-10-21","current":-1.829298,"twenty":-128.917565,"median":-9.40723,"eighty":-2.498192,"marketCap":87946734},{"date":"2022-10-28","current":-1.742102,"twenty":-128.618779,"median":-9.304703,"eighty":-2.457611,"marketCap":84357071},{"date":"2022-11-04","current":-1.683747,"twenty":-128.226247,"median":-9.255989,"eighty":-2.39317,"marketCap":82185325},{"date":"2022-11-11","current":-1.663635,"twenty":-128.209846,"median":-9.163061,"eighty":-2.367847,"marketCap":82562240},{"date":"2022-11-18","current":-1.888259,"twenty":-128.20656,"median":-6.657802,"eighty":-2.347311,"marketCap":82363731},{"date":"2022-11-25","current":-1.866736,"twenty":-127.835038,"median":-6.514433,"eighty":-2.291772,"marketCap":81417021},{"date":"2022-12-02","current":-1.56013,"twenty":-127.552772,"median":-5.96085,"eighty":-2.25148,"marketCap":67576128},{"date":"2022-12-09","current":-1.468126,"twenty":-127.160556,"median":-5.58722,"eighty":-2.236928,"marketCap":62861514},{"date":"2022-12-16","current":-1.17733,"twenty":-127.053152,"median":-5.38233,"eighty":-2.171861,"marketCap":50156672},{"date":"2022-12-23","current":-1.358228,"twenty":-127.026762,"median":-5.287986,"eighty":-2.151516,"marketCap":58317308},{"date":"2022-12-30","current":-1.305127,"twenty":-127.012199,"median":-4.88642,"eighty":-2.078414,"marketCap":56253481},{"date":"2023-01-06","current":-1.721971,"twenty":-126.613746,"median":-4.786575,"eighty":-2.064535,"marketCap":74581778},{"date":"2023-01-13","current":-1.958893,"twenty":-125.887549,"median":-4.725975,"eighty":-2.064448,"marketCap":85203859},{"date":"2023-01-20","current":-1.771234,"twenty":-125.578761,"median":-4.66151,"eighty":-2.043983,"marketCap":77062157},{"date":"2023-01-27","current":-1.727979,"twenty":-125.032785,"median":-4.60677,"eighty":-2.039319,"marketCap":75717830},{"date":"2023-02-03","current":-1.911149,"twenty":-124.433025,"median":-4.567095,"eighty":-2.018884,"marketCap":83310440},{"date":"2023-02-10","current":-1.812701,"twenty":-124.190962,"median":-4.533789,"eighty":-2.002662,"marketCap":79144918},{"date":"2023-02-17","current":-2.221568,"twenty":-123.411777,"median":-4.492199,"eighty":-2.002662,"marketCap":85341926},{"date":"2023-02-24","current":-2.569521,"twenty":-121.025981,"median":-4.397751,"eighty":-2.011467,"marketCap":97865569},{"date":"2023-03-03","current":-2.376045,"twenty":-120.51029,"median":-4.26529,"eighty":-2.012119,"marketCap":90481346},{"date":"2023-03-10","current":-2.144412,"twenty":-120.03546,"median":-4.107634,"eighty":-2.014757,"marketCap":80734171},{"date":"2023-03-17","current":-2.03249,"twenty":-119.685884,"median":-4.011431,"eighty":-2.017977,"marketCap":76776228},{"date":"2023-03-24","current":-2.061672,"twenty":-118.876524,"median":-3.981384,"eighty":-2.014757,"marketCap":77760791},{"date":"2023-03-31","current":-1.977626,"twenty":-117.78219,"median":-3.94901,"eighty":-1.987121,"marketCap":75811356},{"date":"2023-04-06","current":-1.91452,"twenty":-117.160879,"median":-3.9399,"eighty":-1.984882,"marketCap":73645317},{"date":"2023-04-14","current":-1.947254,"twenty":-116.991047,"median":-3.90996,"eighty":-1.977476,"marketCap":75614443},{"date":"2023-04-21","current":-1.896317,"twenty":-115.028974,"median":-3.89543,"eighty":-1.971212,"marketCap":73054579},{"date":"2023-04-28","current":-1.634642,"twenty":-113.997074,"median":-3.880082,"eighty":-1.965507,"marketCap":62342533},{"date":"2023-05-05","current":-1.648475,"twenty":-112.858131,"median":-3.842567,"eighty":-1.961435,"marketCap":62952962},{"date":"2023-05-12","current":-1.561561,"twenty":-112.34852,"median":-3.809653,"eighty":-1.957233,"marketCap":60058347},{"date":"2023-05-19","current":-1.537738,"twenty":-111.975791,"median":-3.777356,"eighty":-1.947092,"marketCap":59073784},{"date":"2023-05-26","current":-1.436356,"twenty":-111.824676,"median":-3.752727,"eighty":-1.942221,"marketCap":54643250},{"date":"2023-06-02","current":-1.443176,"twenty":-111.655623,"median":-3.696747,"eighty":-1.935447,"marketCap":55582677},{"date":"2023-06-09","current":-1.264297,"twenty":-111.00473,"median":-3.683273,"eighty":-1.92452,"marketCap":49104996},{"date":"2023-06-16","current":-1.466169,"twenty":-110.38808,"median":-3.601713,"eighty":-1.918147,"marketCap":57463294},{"date":"2023-06-23","current":-1.648865,"twenty":-108.460388,"median":-3.467278,"eighty":-1.912497,"marketCap":64940186},{"date":"2023-06-30","current":-2.192814,"twenty":-105.810072,"median":-3.376736,"eighty":-1.906757,"marketCap":78616305},{"date":"2023-07-07","current":-2.885909,"twenty":-105.776476,"median":-3.310769,"eighty":-1.911149,"marketCap":102543007},{"date":"2023-07-14","current":-2.74504,"twenty":-98.755875,"median":-3.247232,"eighty":-1.91452,"marketCap":99338538},{"date":"2023-07-21","current":-2.372751,"twenty":-98.031589,"median":-3.183361,"eighty":-1.914949,"marketCap":85473869},{"date":"2023-07-28","current":-2.306055,"twenty":-95.934049,"median":-3.130529,"eighty":-1.918046,"marketCap":82995746},{"date":"2023-08-04","current":-2.170072,"twenty":-94.762182,"median":-3.091978,"eighty":-1.918215,"marketCap":77242321},{"date":"2023-08-11","current":-2.366827,"twenty":-94.218756,"median":-2.980874,"eighty":-1.919822,"marketCap":83876034},{"date":"2023-08-18","current":-2.171373,"twenty":-84.307216,"median":-2.962089,"eighty":-1.920017,"marketCap":78596284},{"date":"2023-08-25","current":-2.035111,"twenty":-82.563065,"median":-2.913966,"eighty":-1.923259,"marketCap":73436528},{"date":"2023-09-01","current":-2.060777,"twenty":-69.570608,"median":-2.891838,"eighty":-1.925361,"marketCap":74516477},{"date":"2023-09-08","current":-2.138993,"twenty":-62.876374,"median":-2.886766,"eighty":-1.926648,"marketCap":76556380},{"date":"2023-09-15","current":-2.186055,"twenty":-61.166511,"median":-2.862466,"eighty":-1.932188,"marketCap":79196255},{"date":"2023-09-22","current":-3.239979,"twenty":-60.156661,"median":-2.862505,"eighty":-1.933531,"marketCap":117594440},{"date":"2023-09-29","current":-3.231051,"twenty":-58.802798,"median":-2.887623,"eighty":-1.936082,"marketCap":117210458},{"date":"2023-10-06","current":-3.603365,"twenty":-58.270931,"median":-2.89227,"eighty":-1.939827,"marketCap":128393929},{"date":"2023-10-13","current":-4.01983,"twenty":-57.280428,"median":-2.913966,"eighty":-1.941352,"marketCap":143993192},{"date":"2023-10-20","current":-3.423708,"twenty":-56.90561,"median":-2.962089,"eighty":-1.942221,"marketCap":122154224},{"date":"2023-10-27","current":-4.996703,"twenty":-56.504715,"median":-2.973705,"eighty":-1.942429,"marketCap":176866702},{"date":"2023-11-03","current":-5.329509,"twenty":-54.656032,"median":-3.010363,"eighty":-1.943305,"marketCap":189158472},{"date":"2023-11-10","current":-4.560713,"twenty":-52.742366,"median":-3.091978,"eighty":-1.94625,"marketCap":162200020},{"date":"2023-11-17","current":-4.996114,"twenty":-51.258965,"median":-3.130529,"eighty":-1.946607,"marketCap":184717387},{"date":"2023-11-24","current":-5.116431,"twenty":-51.093324,"median":-3.170581,"eighty":-1.947254,"marketCap":189981852},{"date":"2023-12-01","current":-4.938796,"twenty":-50.393945,"median":-3.230598,"eighty":-1.950248,"marketCap":185088380},{"date":"2023-12-08","current":-4.561204,"twenty":-50.376624,"median":-3.247232,"eighty":-1.95213,"marketCap":170654694},{"date":"2023-12-15","current":-4.500422,"twenty":-49.399291,"median":-3.269411,"eighty":-1.954618,"marketCap":170695815},{"date":"2023-12-22","current":-4.130437,"twenty":-49.277645,"median":-3.3556,"eighty":-1.957887,"marketCap":157989237},{"date":"2023-12-29","current":-4.310445,"twenty":-32.061942,"median":-3.402382,"eighty":-1.958267,"marketCap":166131316},{"date":"2024-01-05","current":-4.318376,"twenty":-20.481568,"median":-3.423708,"eighty":-1.958595,"marketCap":164486452},{"date":"2024-01-12","current":-4.563291,"twenty":-20.013341,"median":-3.49542,"eighty":-1.959075,"marketCap":172710775},{"date":"2024-01-19","current":-3.92932,"twenty":-19.792243,"median":-3.565262,"eighty":-1.959801,"marketCap":148037807},{"date":"2024-01-26","current":-3.950798,"twenty":-19.709624,"median":-3.603365,"eighty":-1.961843,"marketCap":148860239},{"date":"2024-02-02","current":-3.944818,"twenty":-19.250755,"median":-3.632115,"eighty":-1.962705,"marketCap":149682671},{"date":"2024-02-09","current":-3.615493,"twenty":-19.093034,"median":-3.631699,"eighty":-1.963012,"marketCap":136523755},{"date":"2024-02-16","current":-2.680715,"twenty":-18.477492,"median":-3.618101,"eighty":-1.963978,"marketCap":139813484},{"date":"2024-02-23","current":-3.133488,"twenty":-18.324253,"median":-3.60144,"eighty":-1.965507,"marketCap":163540652},{"date":"2024-03-01","current":-2.756728,"twenty":-18.051925,"median":-3.571727,"eighty":-1.966215,"marketCap":143103211},{"date":"2024-03-08","current":-2.893772,"twenty":-17.988144,"median":-3.509391,"eighty":-1.966365,"marketCap":151409777},{"date":"2024-03-15","current":-3.384484,"twenty":-17.890207,"median":-3.460872,"eighty":-1.96751,"marketCap":176411717},{"date":"2024-03-22","current":-5.948737,"twenty":-17.693612,"median":-3.501848,"eighty":-1.968057,"marketCap":309721734},{"date":"2024-03-28","current":-6.277752,"twenty":-17.593382,"median":-3.537975,"eighty":-1.97044,"marketCap":326822934},{"date":"2024-04-05","current":-6.173002,"twenty":-17.49944,"median":-3.571727,"eighty":-1.974822,"marketCap":322262614},{"date":"2024-04-12","current":-5.625506,"twenty":-17.420148,"median":-3.60144,"eighty":-1.976812,"marketCap":288820267},{"date":"2024-04-19","current":-5.486561,"twenty":-17.268978,"median":-3.62071,"eighty":-1.977327,"marketCap":281143728},{"date":"2024-04-26","current":-5.113399,"twenty":-17.165732,"median":-3.634168,"eighty":-1.978026,"marketCap":262978453},{"date":"2024-05-03","current":-5.174175,"twenty":-17.019522,"median":-3.65189,"eighty":-1.980141,"marketCap":266018667},{"date":"2024-05-10","current":-5.518277,"twenty":-16.703843,"median":-3.690141,"eighty":-1.983748,"marketCap":284107936},{"date":"2024-05-17","current":-5.170287,"twenty":-16.53984,"median":-3.752554,"eighty":-1.985588,"marketCap":267538773},{"date":"2024-05-24","current":-5.156596,"twenty":-16.235819,"median":-3.76177,"eighty":-1.986258,"marketCap":265182608},{"date":"2024-05-31","current":-5.152988,"twenty":-16.017767,"median":-3.776187,"eighty":-1.986691,"marketCap":265714645},{"date":"2024-06-07","current":-4.276168,"twenty":-15.535397,"median":-3.803665,"eighty":-1.986952,"marketCap":220111445},{"date":"2024-06-14","current":-4.302222,"twenty":-14.801178,"median":-3.81929,"eighty":-1.98919,"marketCap":220415467},{"date":"2024-06-21","current":-3.940351,"twenty":-14.571124,"median":-3.835523,"eighty":-1.997464,"marketCap":202630219},{"date":"2024-06-28","current":-3.526311,"twenty":-14.549532,"median":-3.835523,"eighty":-1.998626,"marketCap":201034107},{"date":"2024-07-05","current":-3.50458,"twenty":-14.448525,"median":-3.81929,"eighty":-2.000387,"marketCap":201034107},{"date":"2024-07-12","current":-3.843129,"twenty":-14.147318,"median":-3.809653,"eighty":-2.002662,"marketCap":220263456},{"date":"2024-07-15","current":-4.256175,"twenty":-14.120591,"median":-3.81564,"eighty":-2.004863,"marketCap":243217067},{"date":"2024-08-02","current":-3.727989,"twenty":-14.093863,"median":-3.809653,"eighty":-2.007065,"marketCap":210230752},{"date":"2024-08-09","current":-3.611765,"twenty":-13.805112,"median":-3.777356,"eighty":-2.011858,"marketCap":205974453},{"date":"2024-08-16","current":-3.515283,"twenty":-13.633425,"median":-3.76177,"eighty":-2.013702,"marketCap":201110112},{"date":"2024-08-23","current":-3.526533,"twenty":-13.508125,"median":-3.752554,"eighty":-2.016689,"marketCap":203162256},{"date":"2024-08-30","current":-3.348343,"twenty":-13.412675,"median":-3.696747,"eighty":-2.020698,"marketCap":194725664},{"date":"2024-09-06","current":-2.8625,"twenty":-13.305996,"median":-3.684754,"eighty":-2.024287,"marketCap":165919643},{"date":"2024-09-13","current":-2.648033,"twenty":-13.140858,"median":-3.637194,"eighty":-2.027095,"marketCap":152694715},{"date":"2024-09-20","current":-3.015633,"twenty":-13.088381,"median":-3.634168,"eighty":-2.029369,"marketCap":174246897},{"date":"2024-09-27","current":-3.455566,"twenty":-12.960833,"median":-3.626474,"eighty":-2.032467,"marketCap":201085140},{"date":"2024-10-04","current":-3.108256,"twenty":-12.736179,"median":-3.615973,"eighty":-2.033538,"marketCap":179918283},{"date":"2024-10-11","current":-3.443357,"twenty":-12.592921,"median":-3.603365,"eighty":-2.035592,"marketCap":196200481},{"date":"2024-10-18","current":-3.739413,"twenty":-12.525252,"median":-3.60144,"eighty":-2.03742,"marketCap":212686206},{"date":"2024-10-25","current":-3.8612,"twenty":-12.479621,"median":-3.615493,"eighty":-2.039557,"marketCap":218588502},{"date":"2024-10-31","current":-3.585445,"twenty":-12.42693,"median":-3.616453,"eighty":-2.040304,"marketCap":201695722},{"date":"2024-11-08","current":-4.106384,"twenty":-12.317215,"median":-3.618581,"eighty":-2.040978,"marketCap":232021315},{"date":"2024-11-15","current":-2.536435,"twenty":-12.115323,"median":-3.626474,"eighty":-2.043236,"marketCap":223880217},{"date":"2024-11-22","current":-2.333282,"twenty":-12.026655,"median":-3.615973,"eighty":-2.043983,"marketCap":206783909},{"date":"2024-11-29","current":-2.351634,"twenty":-11.936471,"median":-3.607565,"eighty":-2.04583,"marketCap":207614592},{"date":"2024-12-06","current":-2.413842,"twenty":-11.809548,"median":-3.599514,"eighty":-2.048612,"marketCap":212814958},{"date":"2024-12-13","current":-2.303131,"twenty":-11.72588,"median":-3.588554,"eighty":-2.049905,"marketCap":200814114},{"date":"2024-12-20","current":-2.163376,"twenty":-11.711628,"median":-3.56358,"eighty":-2.050157,"marketCap":186413102},{"date":"2024-12-27","current":-2.110862,"twenty":-11.68813,"median":-3.558797,"eighty":-2.05598,"marketCap":181212737},{"date":"2025-01-03","current":-2.196881,"twenty":-11.654482,"median":-3.539971,"eighty":-2.057926,"marketCap":188213229},{"date":"2025-01-10","current":-2.226212,"twenty":-11.596535,"median":-3.526545,"eighty":-2.058607,"marketCap":191213440},{"date":"2025-01-17","current":-2.078726,"twenty":-11.492556,"median":-3.523531,"eighty":-2.058607,"marketCap":178612554},{"date":"2025-01-24","current":-2.368931,"twenty":-11.420866,"median":-3.518289,"eighty":-2.059237,"marketCap":203814325},{"date":"2025-01-31","current":-2.325371,"twenty":-11.377461,"median":-3.516612,"eighty":-2.05986,"marketCap":199614030},{"date":"2025-02-07","current":-2.176887,"twenty":-11.267085,"median":-3.511957,"eighty":-2.060956,"marketCap":188213229},{"date":"2025-02-14","current":-2.72547,"twenty":-11.233508,"median":-3.508297,"eighty":-2.062223,"marketCap":199210180},{"date":"2025-02-21","current":-2.682137,"twenty":-11.224021,"median":-3.504742,"eighty":-2.064427,"marketCap":196265151},{"date":"2025-02-28","current":-2.424652,"twenty":-11.119887,"median":-3.503277,"eighty":-2.064479,"marketCap":174598151},{"date":"2025-03-07","current":-2.152247,"twenty":-11.018089,"median":-3.501627,"eighty":-2.064618,"marketCap":156927977},{"date":"2025-03-14","current":-2.12991,"twenty":-11.010445,"median":-3.490365,"eighty":-2.06633,"marketCap":153562229},{"date":"2025-03-21","current":-2.138726,"twenty":-10.983429,"median":-3.477723,"eighty":-2.069377,"marketCap":155034744},{"date":"2025-03-28","current":-2.034188,"twenty":-10.922933,"median":-3.466627,"eighty":-2.06633,"marketCap":147672171},{"date":"2025-04-04","current":-1.694307,"twenty":-10.866274,"median":-3.459606,"eighty":-2.061672,"marketCap":125374094},{"date":"2025-04-11","current":-1.628954,"twenty":-10.802213,"median":-3.44878,"eighty":-2.058253,"marketCap":120746191},{"date":"2025-04-17","current":-2.091006,"twenty":-10.763364,"median":-3.4153,"eighty":-2.05809,"marketCap":156717617},{"date":"2025-04-25","current":-1.985003,"twenty":-10.735709,"median":-3.384484,"eighty":-2.049646,"marketCap":148513608},{"date":"2025-05-02","current":-1.854992,"twenty":-10.710414,"median":-3.361363,"eighty":-2.04345,"marketCap":139257802},{"date":"2025-05-08","current":-1.7477,"twenty":-10.655885,"median":-3.348784,"eighty":-2.039796,"marketCap":130633074}],"updateTime":1746780882150}}}